$1.5 million was raised in a seed investment round to support the development of its futuristic automated external defibrillators by Hearthero, a medtech startup.
A New York-based company named Siga Technologies has won FDA approval for its oral formulation of tecovirimat, used to treat smallpox, in case there occurs an outbreak.
In a joint venture, German biopharmaceutical firm BioNTech and Genevant Sciences, a genetic disorder therapeutics maker plan to develop mRNA therapy programmes targeting rare diseases with severely deficient medical attention.
The US-based RAZOR (Randomised Open versus Robotic Cystectomy) trial revealed that robotic surgery is equally effective as traditional open surgery in order to treat bladder cancer. The study was funded by the National Cancer Institute and the discovery was published in the Lancet.
EchoNous announced that it has been granted FDA 510(k) clearance for its EchoNous Vein ultrasound device which could improve peripheral IV catheter placements. This system could provide real-time clear mages of superficial and deeper veins.
iBeat, a San Francisco-based start-up, launched a new pulse sensitive feature called iBeat Heart Watch which alerts healthcare professionals if it detects someone going into cardiac arrest.
Onychomycosis is a fungal infection that causes nail disfigurement, pain and infection and impacts millions of people throughout the world. Though several antifungal treatments are currently available, they often fail for various reasons.
The healthcare sector has gained its entry into the new era of genomics and precision medicine. There are numerous health IT vendors, who offer to help healthcare providers by providing the right data with the objective of utmost patient care.
According to nutritionists, combing certain foods amplifies their positive effects on your body. We have listed the top 5 recommended combinational foods herewith:
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.